Small NZ drugmaker outperforms global pharma giants on revenue per employee
A New Zealand pharmaceutical company is generating more revenue per employee than Pfizer and Merck, bolstered by international trials and FDA approvals.
A small New Zealand drugmaker is outperforming major global pharmaceutical companies like Pfizer and Merck when measured by revenue per employee. The company's strong performance is being driven by international clinical trials and new approvals from the US Food and Drug Administration.
Covered byNewsroomNot covered byRNZStuffNZ Herald1NewsNewstalk ZBOtago Daily TimesThe SpinoffBusinessDeskinterest.co.nz
Coverage across the news outlets we track, as at publication.
What outlets are saying
Newsroom
Small NZ drugmaker quietly outperforms global giants Pfizer and Merck
Business & investing: A small NZ pharma firm is beating global giants on per-employee revenue, driven by international trials and new FDA approvals